ZNF280A Promotes Proliferation and Tumorigenicity via Inactivating the Hippo-Signaling Pathway in Colorectal Cancer
Authors:
Open Access
- 24 January 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 12, 204-213
Abstract
No abstract availableKeywords
Funding Information
- Department of Finance of Jilin Province (3D5178963428)
This publication has 34 references indexed in Scilit:
- A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β‐catenin signallingThe EMBO Journal, 2012
- Hippo signaling: growth control and beyondDevelopment, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liverProceedings of the National Academy of Sciences, 2010
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2009
- Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profilingBlood, 2009
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo PathwayMolecular and Cellular Biology, 2008
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005